top of page
The safety and efficacy of psilocybin is proven in hundreds of clinical studies allievating depression, anxiety, PTSD, and the promotion of neuroplasticity.
Clinical study at a glance
89%
of clients reported improvement in their depression and anxiety symptoms after 3 sessions
62%
of participants who reported suicidal ideation no longer reported any suicidal ideation after 4 sessions
95%
of clients reported no side effects from their psilocybin treatment with HaloxStem
30%
of clients experiencing depression and anxiety achieved remission (or virtually no symptoms) after 4 sessions
Safety Information
Exceptional outcomes
Compared to studies of traditional treatments, HaloxStem produced greater improvements in symptoms of anxiety and depression.
SSRI Antidepressants
Psychotherapy
41%
47%
Psilocybin therapy
IV Ketamine
54%
63%
Percent of Patients with >50% Reduction of Depression Symptoms
Safety Information
Learn more about the landmark clinical study of at-home psilocybin therapy
bottom of page